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pathways associated to varicocele and to male infertility. Studying 
the secreted proteins in the male reproductive tract has become a 
promising area to determine the reproductive biology of semen as well 
as to improve the diagnosis of male infertility.20 Specifically, proteins 
present in the seminal plasma may contain important information 
regarding testicular function, especially because around 10% of the 
proteins found in seminal plasma arise from the testes.21
Therefore, we have reviewed the importance of studying the 
seminal plasma protein profile, as well as thoroughly reviewed the 
current literature on seminal plasma proteomics in male infertility, in 
general, with a specific focus on varicocele and its treatment. Moreover, 
we have discussed current challenges in undertaking these studies, as 
well as the future outlook derived from the growing body of evidence 
on the seminal proteome.
REVIEW CRITERIA
We have performed a literature search using PubMed and Google 
Scholar electronic databases, with the following keywords: “seminal 
plasma AND proteomics;” “Seminal plasma AND proteomic;” 
“Seminal plasma AND proteome;” “Seminal plasma proteomics;” 
“Seminal plasma proteomic;” “Seminal plasma proteome;” “Varicocele 
AND proteomics;” “Varicocele AND proteomic;” “Varicocele AND 
proteome;” “Varicocele proteomics;” “Varicocele proteomic;” and 
“Varicocele proteome.” Only articles written in English published in 
peer reviewed journals were selected. The search was performed in 
June and July, 2015, and covered all articles published until this date.
PROTEOMICS AS A TOOL FOR THE STUDY OF MALE 
INFERTILITY
Proteomics is a term used to define the comprehensive study of all 
the proteins of any given fluid or a cell under a specific biological 
INTRODUCTION
Varicocele is the most important treatable cause of male infertility. 
Defined as the presence of dilated veins within the pampiniform plexus 
with blood reflux,1 its reported prevalence is 15% of the adult male 
population.2 The fact that it is detected in 35% of men with primary 
infertility, and in up to 80% of men with secondary infertility,2,3 has led 
to the proposal that varicocele progressively causes a decline in male 
fertility potential.2 Moreover, because adolescents with varicocele may 
present with decreased ipsilateral testicular volume, it has also been 
proposed that varicocele initiates its effect on puberty onset.4
Treatment of varicocele, usually through surgical ligation of the 
dilated veins,5 is associated to a catch-up growth of the affected testis in 
adolescents,6 and to improve semen quality and fertility in adult men.7–9 
However, some conflicting results have been reported which, associated 
to the fact that 80% of adult men with varicocele will not present with 
infertility,10 has led to the need to differentiate a varicocele that is exerting 
a deleterious effect (and that is treatable) from a “silent” varicocele.
While diagnosis of varicocele is performed by a clinical work-up 
that includes a physical exam and may include scrotal ultrasonography,11 
diagnosing a varicocele that is indeed determining infertility or, in 
adolescents, which will lead to infertility, is not so easily achieved. Therefore, 
a number of reports have attempted to increase sensitivity in diagnosing an 
infertility-defining varicocele, mainly through the use of semen oxidative 
stress12–15 and sperm functional integrity testing.6,15–18 While these studies 
have increased sensitivity in detecting testicular dysfunction in varicocele, 
there is still a need to determine possible effective markers of a deleterious 
varicocele, in order to improve patient screening for treatment.
Despite the growing evidence of the cellular effects of varicocele, its 
underlying molecular mechanisms still elude clinicians and scientists.19 
Many studies have thus focused on determining the molecular 
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condition.22 Proteins are effector molecules within a general cascade 
that initiates with Genomics studies, through Transcriptomics down 
to Proteomics and Metabolomics.23 Because proteins integrate an 
individual response to environmental conditions, as well as effect 
a given biological response,23 recent studies which focused on 
understanding the mechanisms of diseases have deployed great 
efforts toward understanding not only the proteins present in a given 
situation, but also their quantities, interactions, and post-translational 
modifications, as well as the pathways they enrich.24–27
Current developments in separation techniques as well as in mass 
spectrometry equipment have greatly increased our ability to delve deep 
into the proteome of cells and fluids.28 This is of particular interest to 
biological conditions in which phenotypic differences are determined by 
proteins in lower quantities. In seminal plasma, 15 proteins may account 
to up to 90% of the amount of protein (data not published), which means 
that more often the proteins that determine male infertility will be 
present in the remaining 10%. Moreover, seminal plasma is composed of 
fluids secreted from the seminal vesicles, prostate, bulbourethral glands 
and the vas deferens, epididymides, and seminiferous tubule lumen.29 
Therefore, proteins secreted from the testes, which more likely represent 
testicular function, will be present at very low quantities, and increased 
sensitivity and dynamic ranges are essential in order to understand the 
molecular mechanisms of male infertility.
Shotgun proteomics studies, which are untargeted studies 
based on extensive mapping of generated protein digests, allow 
identification of a large number of expressed proteins in the seminal 
plasma, focusing on understanding their functions, interactions, and 
contribution to biological processes.30 These studies are based on mass 
spectrometry (MS) identification and quantification of proteins.
Briefly, mass spectrometers are subdivided into (i) an ionization 
source, such as matrix-assisted laser desorption ionization (MALDI) 
and electrospray ionization  (ESI),  (ii) mass analyzer(s), such as 
quadrupole  (Q) and time-of-flight  (TOF), and  (iii) a detector. For 
peptide identification, ionized peptides can be fragmented in a collision 
chamber coupled to a high resolution mass analyzer, in an approach 
termed tandem MS (MS/MS).31 In addition, MS can be coupled to liquid 
chromatography  (LC-MS/MS), enabling separation  (fractionation) 
of peptides to decrease sample complexity, as well as generating 
quantitative information.32 Prior to MS, samples may be separated by 
one-dimensional (1DE) or two-dimensional electrophoresis (2DE), in 
order to reduce sample complexity in the protein level, leading to the 
possibility of observing proteins present at smaller amounts. In 1DE, 
proteins are separated by their molecular masses, whereas in 2DE 
proteins are also separated by their isoelectric point (pH in which the 
protein has no electrical charge).33,34 In both cases, the bands or spots 
of interest are excised from the gel and analyzed by MS. For proteomic 
data validation, selected reaction monitoring (SRM) allows for absolute 
protein quantification, in a targeted MS approach.35 The different 
techniques used for proteomics studies were recently reviewed by 
Scherl.31 Shotgun proteomics can be applied both to describe the whole 
seminal plasma proteome and to compare the proteomes between 
different infertility conditions, which will be further described below.
ORIGIN AND CHARACTERIZATION OF THE SEMINAL 
PLASMA PROTEOME
The seminal plasma components, secreted from the testes, the cauda 
epididymis and the accessory sexual glands, protect the sperm during 
their transit through the female reproductive tract, playing major roles for 
sperm survival, function, motility and viability, as well as for successful 
fertilization.29,36–39 In particular, seminal plasma proteins are capable of 
binding and fusing to the sperm membrane to regulate its survival after 
ejaculation,40 motility,41–43 capacitation40,44 and interaction and fusion 
with the oocyte.45 Moreover, seminal plasma proteins are capable of 
interacting with the female genital tract epithelium, to regulate sperm 
transport and female immune response.46 The main functions of seminal 
plasma proteins were reviewed in depth by Rodríguez-Martínez et al.47
Seminal plasma is rich in extra and intracellular proteins, with 
a mean total protein concentration of 35–55 g l−1.39 The majority of 
seminal plasma proteins are spermadhesins, cysteine-rich secretory 
proteins (CRISPs), proteins carrying fibronectin type II domains and 
enzymes.48 Approximately, 70% of the protein content of seminal plasma 
is secreted from the seminal vesicles, such as semenogelin-1 (SEMG1) 
and semenogelin-2 (SEMG2), important proteins for semen coagulation 
after ejaculation, lactotransferrin (LTF), and fibronectin (FN1).49 Another 
20% of seminal plasma proteins are secreted from the prostate (three 
main proteins regulated by hormones: prostate-specific antigen – KLK3, 
important for semen liquefaction, prostatic acid phosphatase – ACPP, and 
beta-microseminoprotein - MSMB) and the bulbourethral glands (mainly 
mucins).48,50,51 Finally, approximately 10% of seminal plasma proteins are 
of testicular or epididymal origin.21 It has already been shown that proteins 
associated with testicular function, as well as proteins from altered 
sperm present throughout the male reproductive tract, are observed in 
the seminal plasma.39,52,53 Therefore, the seminal plasma protein profile 
reflects not only the activity of the male sexual accessory glands, but also 
spermatogenesis, epididymal maturation and sperm integrity.
SEMINAL PLASMA PROTEOMICS AND MALE INFERTILITY
A summary of studies focusing on the seminal plasma proteome in 
fertile men and men with varicocele is presented in Tables  1 and 
2, respectively. Characterization of the seminal plasma proteome 
is important in order to determine, as best as possible, a normal 
state  (Table  1). In men with normal semen analysis, Fung et  al.54 
identified, utilizing different approaches, over  100 proteins, such 
as SEMG1, SEMG2, KLK3, ACPP, albumin  (ALB), and prolactin 
inducible protein  (PIP). Furthermore, Pilch and Mann39 later 
reported, by the use of 1DE followed by LC-MS/MS, 923 proteins 
in seminal plasma of one healthy donor. From the 52% of proteins 
with an assigned subcellular location, 78% were cellular proteins and 
25% were extracellular or secreted proteins (including proteins from 
prostasomes), demonstrating that the seminal plasma is composed of 
many more secreted proteins than other fluids. The seminal plasma 
proteome described in that study presented with 66% homology with 
the prostate fluid and 18% with the epididymal fluid, while 38% were 
common to all fluids.55
In 2012, Milardi et al.52 evaluated the seminal plasma of 5 men 
with proven fertility, and identified between 919 and 1487 proteins 
per sample, of which 83 were observed in all five samples, such as 
SEMG1, SEMG2, LTF, olfactory receptor 5R1 (OR5R1), clusterin (CLU), 
and E3 ubiquitin-protein ligase UBR5 (UBR5). Rolland et al.56 then 
demonstrated, in a healthy donor, a total of 669 proteins which integrated 
to data from previous studies, accounted for 2545 seminal plasma 
proteins. These proteins were mostly involved in protein binding (~50%) 
and catalytic activity (~39%), and were mainly cytoplasmic (58.7%, such 
as proteins found in vesicles and the endomembrane system or in the 
cytoskeleton) or extracellular (21.2%) proteins. The authors suggested 
that seminal plasma lacks nucleic acid-binding proteins, transcription 
regulators, and membrane receptors and channels. These proteomic 
results were also compared to gene expression data from testis, 
epididymis and prostate, available in public databases, to identify the 
contribution of these organs to the seminal plasma proteome. Using this 
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approach, the authors identified 83 testicular proteins, 42 epididymal 
proteins, 7 seminal vesicles proteins, and 17 prostatic proteins.56
These studies have established the seminal plasma proteome 
associated with men presenting with normal semen analysis or of 
proven fertility. To compare the seminal plasma proteome between 
fertile men and men with different infertility conditions, several 
studies were performed, as described in Supplementary Table 1. These 
studies have been performed mainly in the search for biomarkers of 
infertility, and, in this context, seminal plasma is a promising source, 
because it presents high concentrations of proteins, many of which are 
tissue-specific (testicular proteins, for instance), as well as non secreted 
proteins (arriving, for example, from altered sperm).57
One of the most studied causes of infertility using a proteomics 
approach thus far is azoospermia. In men after vasectomy (mimicking 
obstructive azoospermia) and with nonobstructive azoospermia (Sertoli 
cell-only syndrome  –  SCOS), several proteins, such as CLU, were 
underexpressed compared to controls, and are potential biomarkers 
of impaired spermatogenesis.58,59 To identify the contribution of the 
testis and epididymis to the human seminal plasma proteome, fertile 
and vasectomized  (mimicking obstructive azoospermia) men were 
compared.21 Thirty-two proteins were uniquely presented in the fertile 
group (testicular and epididymal proteins). In the vasectomy group, 
49 proteins were underexpressed (proteins expressed in the testis and 
epididymis, but also in other regions of the male reproductive tract). The 
identified testicular and epididymal proteins, such as testis-expressed 
sequence 101 protein (TEX101), have important reproductive functions 
and may be potential biomarkers of obstructive azoospermia.
In a follow-up study,20 5 men with nonobstructive azoospermia 
were evaluated and the obtained data were compared to their previous 
study.21 Sorbitol dehydrogenase  (SORD) was able to differentiate 
between obstructive and nonobstructive azoospermia and was thus 
suggested as a potential biomarker, in addition to several proteins 
suggested in another study as biomarkers of nonobstructive 
azoospermia and obstructive azoospermia, such as NPC2 and PIP, 
respectively.60 Furthermore, a study was performed to narrow down 
the potential biomarker candidates for differential diagnosis of 
azoospermia,61 and 18 proteins were selected to be further analyzed 
by multiplex SRM.62 Extracellular matrix protein 1 (ECM1) levels were 
higher in fertile men and in men with nonobstructive azoospermia, 
but highly decreased in vasectomized men, differentiating these 
conditions with high specificity and sensitivity.62 On the other hand, 
TEX101 levels were higher in fertile men and undetectable in SCOS 
and postvasectomy samples.62 These data might increase the confidence 
in nonobstructive azoospermia and obstructive azoospermia diagnosis 
using these two biomarkers, and facilitate the prediction of testicular 
sperm extraction (TESE) outcome.
To study only nonobstructive azoospermia, Freour et  al.63 
classified men as Sperm Positive  (presenting with sperm in TESE) 
or Sperm Negative (absence of sperm in TESE). Sixty-eight proteins 
were differentially expressed, of which they selected CLU, PIP and 
galectin-3-binding protein (LGALS3BP) as potential spermatogenesis 
biomarkers in the seminal plasma. LGALS3BP was further confirmed 
by ELISA and presented in higher levels in Sperm Positive samples, 
with a concentration lower than 153 ng ml−1 associated with a negative 
TESE outcome. Finally, Rolland et al.56 demonstrated that L-lactate 
dehydrogenase C chain (LDHC), phosphoglycerate kinase 2 (PGK2), 
and transketolase-like protein 1  (TKTL1) proteins are not  (or less) 
observed in the seminal plasma from nonobstructive azoospermia, 
obstructive azoospermia and vasectomized men, suggesting that these 
proteins may be biomarkers of male fertility.
In addition to studies focusing on azoospermia, other infertility 
conditions were also evaluated. In smokers with varicocele, several proteins 
were related to smoking, such as annexin A3 (ANXA3) and extracellular 
superoxide dismutase  [Cu-Zn]  (SOD3) in moderate smokers  (<20 
cigarettes a day), and zinc-alpha-2-glycoprotein  (AZGP1) in heavy 
smokers.64 In men with impaired spermatogenesis  (oligozoospermia, 
asthenozoospermia, and/or teratozoospermia), several proteins were 
altered, and, interestingly, oxidative stress was the major mechanism 
suggested to play a role in these alterations.41,65–67 In men with spinal 
cord injury, overexpressed proteins were mostly involved with smooth 
muscle function, cytoskeletal binding, homeostasis, oxidation of iron and 
response to calcium. This study demonstrated that the method of semen 
retrieval in these patients may also alter the obtained proteome.68 Finally, in 
androgen deficiency, it was demonstrated that the semen of these patients 
Table 1: Descriptive seminal plasma proteomics studies in men with normal semen analysis or of proven fertility
Authors Year Study design MS strategy Identified and differentially 
expressed proteins
Mainly molecular functions 
and biological processes
Fung et al. 2004 5 normal men Pooled proteins
MALDI‑TOF/MS and LC‑MS/MS, after 1DE 
and 2DE and in unfractionated samples
100 proteins were identified ‑
Pilch and 
Mann
2006 3 nonliquefied samples 
from 1 healthy donor
Individual samples
1DE followed by LC‑MS/MS
923 proteins were identified Enzymatic or binding activity
Protease inhibition
Signal transduction
Transport
Metabolism
Milardi et al. 2012 5 men with proven 
fertility
Individual samples
LC‑MS/MS
919–1487 proteins were identified per 
sample, of which 83 were common to 
all samples
Binding activity
Catalytic activity
Molecular structure
Enzyme regulation
Cell process
Regulation
Interaction with cell
Developmental process
Response to stimulus
Rolland et al. 2013 Nonliquefied samples 
from 1 healthy donor
Pooled proteins
NanoLC‑MS/MS
Integration to data from previous studies
669 proteins were identified in this study, 
accounting for a total of 2545 proteins 
identified so far (integrated data)
Protein binding
Catalytic activity
MS: mass spectrometry; MALDI‑TOF: matrix‑assisted laser desorption ionization time‑of‑flight; LC‑MS/MS: liquid chromatography‑mass spectrometry; 1DE: one‑dimensional electrophoresis; 
2DE: two‑dimensional electrophoresis
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lacks proteins mostly involved with catalytic and binding activities, and 
hydrolase is the most impaired enzyme by testosterone deficiency.69
Several studies were also carried out in order to verify if the seminal 
plasma proteome reflects oxidative status and sperm function. Seminal 
Table 2: Descriptive proteomics studies in adolescents and adult men with varicocele
Author Year Object of 
study
Study MS strategy Identified and differentially expressed proteins Main molecular functions
Fariello 
et al.
2012 Human 
seminal 
plasma
56 adult nonsmokers with 
varicocele
29 adult moderate smokers 
with varicocele
25 adult heavy smokers with 
varicocele
Pooled samples
2DE
LC‑MS/MS
20 identified proteins
4 proteins in nonsmokers
5 proteins in moderate smokers
1 proteins in heavy smokers
Lipid catabolic process
Inflammatory
Proteolysis
Apoptosis
Zylbersztejn 
et al.
2013 Human 
seminal 
plasma
21 adolescents without 
varicocele
28 adolescents with varicocele 
and normal semen analysis
18 adolescents with varicocele 
and altered semen analysis
Pooled samples
2DE
ESI MS/MS
From 181 to 323 spots per gel
31 proteins in adolescent without varicocele
7 proteins in adolescent with varicocele and 
NSP
11 proteins in adolescents with varicocele 
and ASP
Apoptosis
Spermatogenesis
Inflammatory
Transport of molecules
Immune
Del Giudice 
et al.
2013 Human 
seminal 
plasma
19 adolescents before and 
after varicocelectomy
Pooled samples
2DE
LC‑MS/MS
From 84 to 168 spots per gel
4 proteins overexpressed in prevaricocelectomy 
adolescents
12 proteins exclusive or overexpressed in 
postvaricocelectomy adolescents
Innate immune response
Metal iron binding
Sperm‑binding activity
Camargo 
et al.
2013 Human 
seminal 
plasma
18 adult before and after 
varicocelectomy
Pooled samples
2D nanoUPLC‑ 
ESI‑MSE
316 proteins identified
58 proteins overexpressed or exclusive in 
prevaricocelectomy
38 proteins exclusive in postvaricocelectomy
TPR domain binding
Nitric oxide metabolic process
Eicosanoid biosynthetic 
process
NAD binding
Cellular response to ROS
Hosseinifar 
et al.
2013 Human 
sperm
20 normozoospermic men
20 oligozoospermic men with 
grade III varicocele
2DE
MALDI‑TOF/MS
500 detected spots
73 spots were submitted to MS analysis
10 proteins were identified
1 protein was overexpressed in varicocele 
group
9 underexpressed in varicocele group
Protein transport
Fertilization
Response to stress
Chan et al. 2013 Human 
sperm
20 healthy control subjects
20 varicocele men (grade II)
2DE
MALDI‑TOF/MS
Western blot
15 proteins identified
11 proteins were up‑regulated in varicocele 
group
4 proteins were down‑regulated in varicocele 
group
Expression levels of HSP70 and HSP90 were 
increased in patients with varicocele 
Metabolism
Signal transduction
Cytoskeleton organization
Endocytosis and exocytosis
Chaperones
Hosseinifar 
et al.
2014 Human 
sperm
20 grade III varicocele 
men before and after 
varicocelectomy
2DE
MALDI‑TOF/MS
3 proteins were underexpressed in 
prevaricocelectomy group
Antioxidant
Mitochondrial ATP synthase
Assembly of multimeric 
protein complexes
Agarwal 
et al.
2015 Human 
sperm
10 healthy control men
33 infertile unilateral 
varicocele men
Pooled samples
1DE
LC‑MS/MS
1191 proteins identified
120 proteins were exclusive in control group
38 proteins were exclusive in unilateral 
varicocele group
211 differentially underexpressed or 
overexpressed
Metabolism
Metabolic and inflammatory 
disease
Immune system
Gene expression
Signal transduction
Agarwal 
et al.
2015 Human 
sperm
33 infertile unilateral 
varicocele men
17 infertile bilateral varicocele 
men
Pooled samples
1DE
LC‑MS/MS
31 proteins were exclusive to unilateral 
varicocele group
64 proteins were exclusive to bilateral 
varicocele group
113 proteins were overexpressed in unilateral 
varicocele group
45 proteins underexpressed in unilateral 
varicocele group
Metabolism
Disease
Signal transduction
Immune system
Gene expression
Cell cycle
Protein metabolism
Agarwal 
et al.
2015 Human 
sperm
10 healthy control men
17 infertile bilateral varicocele 
men
Pooled samples
1DE
LC‑MS/MS
33 proteins were exclusive or overexpressed in 
control health men.
40 proteins were exclusive or overexpressed in 
bilateral varicocele men
Metabolism
Immune system
Cell cycle
TM transport
Extracellular matrix 
organization
Soares 
et al.
2013 Rat testis 
tissue
Control rats
Rats submitted to varicocele 
induction
2DE
LC‑MS/MS
Western blot
617 protein spots identified
5 proteins up‑regulated in varicocele group
21 proteins down‑regulated in varicocele group
Signaling
Phosphorylation of focal 
adhesion kinase
MS: mass spectrometry; LC‑MS/MS: liquid chromatography‑mass spectrometry; 2DE: two‑dimensional electrophoresis; ESI: electrospray ionization; UPLC‑ESI‑MS: ultra‑performance liquid 
chromatography‑electrospray ionization tandem mass spectrometry; MALDI‑TOF/MS: matrix‑assisted laser desorption ionization time‑of‑flight mass spectrometry; 1DE: one‑dimensional 
electrophoresis; HSP70: heat‑shock proteins 70; HSP90: heat‑shock proteins 90; TPR: tetratricopeptide repeat; ROS: reactive oxygen species; ATP: adenosine triphosphate; NSP: normal 
semen parameters; ASP: altered semen parameters; NAD: Nicotinamide adenine dinucleotide
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oxidative stress was associated to specific enriched functions such as 
transition metal ion response/homeostasis, reactive oxygen species (ROS) 
detoxification, aging, and cell morphogenesis, differentiation, motility 
and cycle.70,71 Utilizing a similar approach in order to verify mechanisms 
underlying male infertility, another study analyzed the seminal plasma 
proteome in relation to sperm DNA fragmentation in normozoospermic 
men.53 Thirty proteins were altered in men presenting high sperm 
DNA fragmentation, which evidenced acute-phase response, fatty 
acid-binding, vesicle lumen and endoribonuclease activity. Finally, 
fertile and infertile men, irrespective of the cause for the infertility, were 
compared, and 10 proteins were overexpressed in the infertile group, 
although these proteins were not identified by MS/MS.72
More recently, a review was performed to search for all seminal plasma 
proteomics studies in order to obtain the whole list of seminal plasma 
proteins identified so far using different MS approaches. A total of 4,188 
proteins were identified, of which 2,168 were non-redundant proteins 
(identified using UniProtKB/Swiss-Prot reviewed database). These proteins 
were mostly involved with proteolysis and carbohydrate catabolism. The 
authors also demonstrated that different MS techniques might complement 
each other. Moreover, by analyzing several publications on post-translation 
modifications, it was possible to highlight that phosphorylation, 
acetylation, glycosylation and disulfide bonds are the majority of post-
translation modifications present in seminal plasma proteins.73
SEMINAL PLASMA PROTEOMICS AND VARICOCELE
Because varicocele is a complex disease with a number of different 
mechanisms that may determine infertility, the paradigm-shifting 
approach of studying its postgenomic pathways brings the promise 
of understanding, in a more precise manner, the effector pathways 
of varicocele-derived male infertility, as well as predict treatment 
outcomes.74 A summary of studies focusing on the seminal plasma 
proteome in varicocele men and the analysis of its intervention is 
presented in Table 2. Because there are only a few studies regarding 
seminal plasma proteomics in men with varicocele, proteomic analysis 
of spermatozoa is also discussed in this topic.
Proteomic studies regarding the effect of varicocele and its treatment
In adolescents
Zylbersztejn et al.75 compared the proteomic profile of seminal plasma 
of adolescents without varicocele, with varicocele and normal semen 
analysis, and with varicocele and altered semen analysis, using a 2DE 
approach. Forty-seven spots were extracted and submitted to mass 
spectrometry identification. Proteins such as SEMG1 and Insulin-like 
growth factor-binding protein 3  (IGFBP3) were observed in seminal 
plasma of adolescents with varicocele and altered semen, and are 
linked to regulation of apoptosis. Conversely, E3 ubiquitin-protein 
ligase BRE1B (RNF40), Proactivator polypeptide-like 1 (PSAPL1) and 
Epididymal secretory protein E3-beta  (EDDM3B) were observed in 
seminal plasma of adolescents with varicocele and normal seminal analysis. 
The authors concluded that proteins exclusively expressed in seminal 
plasma of adolescents with varicocele could be potential biomarkers for 
early varicocele diagnosis regarding the negative impact of varicocele in 
the testes, even those found in patients with normal seminal parameters.75
To study the effect of varicocelectomy in seminal plasma proteome 
of adolescents, Del Giudice et  al.76 used 2DE analysis followed by 
LC-MS/MS for spot identification. The authors observed that 19 spots 
were differentially or exclusively expressed, and determined that two 
proteins were overexpressed before varicocelectomy: DNA-directed 
RNA polymerase III subunit RPC2 (POLR3B) and Negative elongation 
factor E (NELFE). At 3 months postvaricocelectomy, 6 proteins were 
exclusively expressed or overexpressed, including SEMG1, SEMG2, 
ACPP, KLK3, TGM4, and alpha-1-antitrypsin  (SERPINA1).76 All 
proteins found differentially expressed in postvaricocelectomy group 
play a crucial role in the physiological process of ejaculation, thus a 
shift-back to homeostasis can be observed after varicocelectomy.77
In adults
In order to verify the effect of varicocelectomy in men, Camargo et al.74 
studied seminal plasma of men who underwent varicocelectomy 
using a label-free shotgun proteomics approach. In total, 316 
proteins were identified and quantified, of which 58 proteins were 
overexpressed or exclusively expressed in the prevaricocelectomy 
men, and 38 were exclusively expressed in the postvaricocelectomy 
men. In prevaricocelectomy group, the proteins CLU, annexin 
A5  (ANXA5), L-lactate dehydrogenase A chain  (LDHA), 14-3-3 
protein epsilon  (YWHAE), 14-3-3 protein theta  (YWHAQ), Heat 
shock protein HSP 90-beta (HSP90AB1), and Heat shock protein HSP 
90-alpha (HSP90AA1) presented enriched functions such as metabolism 
and regulation of nitric oxide  (NO), and of TPR domain-binding. 
After varicocelectomy, Protein deglycase DJ-1 (PARK7), Superoxide 
dismutase  [Cu-Zn]  (SOD1), Protein S100-A9  (S100A9), Annexin 
A1 (ANXA1), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), 
and cytoplasmic malate dehydrogenase (MDH1) enriched functions 
such as cellular response to ROS, gluconeogenesis, NAD-binding and 
protein stabilization.
Hosseinifar et al.78 characterized the sperm proteome in patients 
with varicocele. The authors studied sperm from normozoospermic 
men (control) and compared these with sperm from oligozoospermic 
men with varicocele using a 2DE approach. From 500 spots initially 
observed, 73 were selected for MALDI-TOF/MS identification. The 
results showed 15 differentially expressed proteins, which include 
SEMG2 and its precursor PARK7, CLU, and 78 kDa glucose-regulated 
protein  (HSPA5), underexpressed in patients with varicocele when 
compared with control men. The authors concluded that heat-shock 
proteins, mitochondrial proteins, and cytoskeleton proteins in sperm 
are affected by varicocele.78 Using the same approach, Chan et al.79 also 
determined 15 proteins differentially expressed between men with and 
without varicocele. After confirmation by Western blotting, heat-shock 
proteins 70 and 90 (HSP70 and HSP90) were found overexpressed in 
sperm of men with varicocele.79
Furthermore, Hosseinifar et  al.80 identified, by using 2DE, 
differences in protein expression in sperm of men submitted 
to varicocelectomy. Three proteins were underexpressed in the 
prevaricocelectomy samples: SOD1, HSPA5, and ATP synthase subunit 
delta, mitochondrial (ATP5D). HSPA5 is a member of HSP70 family,12 
which agrees with their previous results.79 Moreover, Chan et al.79 and 
Camargo et al.74 also observed these proteins in patients with varicocele 
and in prevaricocelectomy patients, respectively, as discussed above. 
Therefore, heat shock proteins seem to be key elements in the adult 
varicocele.
Agarwal et al. recently performed three different studies with 1DE and 
LC-MS/MS to better understand unilateral and bilateral varicocele. When 
sperm proteomics from men with unilateral varicocele and men with 
proven fertility (controls) were compared, 1191 proteins were observed, of 
which 369 proteins were exclusive or differentially expressed between the 
groups.81 From these, 15 proteins were involved in reproductive functions 
such as:  (i) motility, overrepresented by calcium-binding tyrosine 
phosphorylation-regulated protein (CABIR), prostate and testis expressed 
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protein 4  (PATE4), radial spoke head protein 9 homolog isoform 
1 (RSPH 9), dynein heavy chain 17, axonemal (DNAH17), apolipoprotein 
A-I (APOA1), sodium/potassium transporting ATPase subunit alpha-4 
isoform 1 (ATP1A4) and A-kinase anchor protein 3 (AKAP3), which 
were all underexpressed in men with varicocele;  (ii) capacitation, 
overrepresented by SEMG2 and ATP1A4, underexpressed in varicocele 
men;  (iii) hyperactivation and acrosome reaction, overrepresented by 
NPC2, dihydrolipoyl dehydrogenase, mitochondrial  (DLD), acrosin 
precursor (ACR), and cysteine-rich secretory protein 2 (CRISP2), which 
were overexpressed in patients with varicocele, and (iv) zona-pellucida 
binding, overrepresented by sperm surface protein Sp17  (SPA17), 
which was underexpressed in varicocele group and acrosome formation 
associated factor isoform 1 (EQTN), exclusive in controls.81
In another study, the sperm proteomic profile of men with bilateral 
varicocele was compared to men with proven fertility  (controls).83 In 
that study, 73 differentially expressed proteins were observed between 
the groups: 8 exclusive and 25 overexpressed in fertile controls and 7 
exclusive and 33 overexpressed in bilateral varicocele. Two main proteins 
were found and confirmed by Western blotting: (i) T-complex protein 11 
homolog (TCP11), previously located to germ cells of fertile men, and 
(ii) Tektin-3 (TEKT3), which is believed to play a role in low sperm motility 
in men with bilateral varicocele.82 In the third study, when sperm from 
unilateral and bilateral varicocele patients were compared, 31 proteins were 
exclusively expressed in unilateral varicocele group and 64 were exclusively 
expressed in bilateral varicocele.83 The authors demonstrated that specific 
proteins in seminal plasma could perhaps explain why bilateral varicocele is 
more aggressive, such as SEMG1, SEMG2, fibrous sheath CABYR-binding 
protein (FSCB), enkurin (ENKUR), and hyaluronidase PH-20 (SPAM1).83 
However, Hosseinifar et al.78 found SEMG2 underexpressed in patients 
with varicocele when compared with healthy control men, although the 
authors utilized a different technique which may be sensitive to protease 
activity and thus lead to altered results.
In addition, Soares et al.84 studied the effect of varicocele in a rat 
animal model. After varicocele induction, the testes were removed 
and the homogenates were submitted to 2DE analysis followed by 
LC-MS/MS. Six proteins were up-regulated and 23 were down-regulated 
in varicocele-induced rats when compared to sham-operated rats. 
The authors observed guanine nucleotide binding protein subunit 
beta-2-like 1  (Gnb2l1 – homologous to GNB2L1 in human) and G 
protein coupled estrogen receptor 1 (Gper1 – homologous to GPER1 
in human) up-regulated in testes of rats with induced varicocele, which 
was confirmed by Western blotting analysis. These proteins are linked to 
reduced expression of androgen receptor (AR), suggesting that varicocele 
affects mechanisms that control AR expression and function.86
FINAL REMARKS/EXPERT COMMENTARY
Seminal plasma is a complex mixture with different origins86 and 
differences in composition that may arise from various reasons. 
Isolating factors that arise from fertility-related causes, such as 
molecular pathways of sperm function, is not easily achieved, because 
many diverse conditions potentially alter simply the contribution of 
individual components to the seminal plasma, such as alteration in 
seminal vesicle or prostate function.68 This is an important challenge 
faced by studies in seminal plasma proteomics – understanding the 
origin of the studied proteome. Furthermore, semen is immediately 
coagulated upon ejaculation, followed by proteolytic activity leading 
to liquefaction.87,88 Thus, when the sample is made available for studies, 
important protease and phosphatase activity has usually already taken 
place, which in turn affects the ability of current studies to observe 
peptides and their posttranslational modifications.89
Varicocele remains an elusive disease, in that quite often it will 
be detected in fertile men.10 Differentiating a fertility-compromising 
varicocele, on the other hand, is imperative for the general medical practice, 
if intervention in patients who indeed require an intervention is to be 
achieved. Patient (and disease) individualization is one of the important 
promises proteomics studies bring,24,90 and in the case of varicocele it may 
assist in differentiating deleterious from “silent” varicoceles.
In general, it seems that varicocele leads to a state of homeorhesis, 
or a deviation from homeostasis toward a dynamic equilibrium in 
an altered state, characterized by enrichment of functions such as 
immune response and apoptosis, somewhat competing with important 
functions  (such as fertilization, motility, and zona binding).76 In 
adolescents, for example, correcting varicocele shifts the seminal 
plasma proteome back to its regular state, enriching expected functions 
for semen associated to preserved reproductive function. In adults, a 
general dysfunction is observed in the seminal plasma proteome, and 
functions important for fertilization are underrepresented in these 
patients.
Defining end-points in studies regarding the seminal plasma 
proteome is also important, as these will, in essence, impact the 
importance of the findings. Simply utilizing semen analysis or 
testicular volume to separate groups may lead findings to fall short 
in sensitivity. On the other hand, defining fertility as an end-point 
will insert variability from the female partner into studies, which may 
limit their applicability. Under the same rationale, defining what is 
to be studied is just as important. If, say, one is interested in studying 
testicular function, normalizing the quantitative proteomics studies 
to constitutive testicular proteins may be fundamental to focus in 
on proteins that reflect the testicular and epididymal environments. 
Studying epididymal microvesicles and exosomes (epididymosomes) 
is also a novel approach that has been producing interesting results, 
because epididymal fluid is an important environment to transfer 
proteins participating in key sperm events (including capacitation), 
which has been shown in animals and in humans.91–93 ESPB1 and BSP1, 
for example, bind to specific phospholipids  in the sperm membrane 
(presenting a phosphorylcholine moiety) in order to localize to 
specific sites, where it will mark dead or altered sperm.94 In humans, 
epididymosomes have been shown to present proteins with a diverse 
array of functions, namely as signal transducers, adhesion, transporter 
and protein trafficking, defense, chaperones, enzymes and structural 
proteins. RAB proteins, for example, seem to participate in determining 
membrane location targeting for individual epididymosomes proteins. 
Because these are docked onto membranes and form an integral part 
of the mature sperm membrane, epididymosomes transfer of proteins 
characterizes an important step in sperm maturation.92
As the seminal plasma proteomics data are amounting to the 
point that tens of thousands of peptides and thousands of proteins 
are observed in small portions of the seminal plasma, it will be 
essential to bear in mind that (i) these studies originate from a clinical 
setting and produce results with a clinical impact, based on medical 
information and a true Cartesian hypothesis, and  (ii) data filtering 
and analysis will be of essence if these data are to be transformed into 
actionable information, such as protein diagnostic and therapeutic 
targets. Functional studies that characterize the events downstream 
of protein pathways will further help in determining biomarkers 
of male fertility.95 This translates to the fact that, as is the case with 
medicine, in general, the study of varicocele and male infertility will 
require a multidisciplinary effort and an integrative approach toward 
data analysis. It may be that the understanding of varicocele and its 
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underlying molecular mechanisms is more at hand now than it ever 
was, as long as all the generated data don’t get in the way!
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